ArticleHealth economics review2025

Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50-69 to 45 and/or 74: A cohort modelling study in the Finnish setting.

Filip Siegfrids et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.